PAULA WOLL: Open Payments
NPI 1942923065 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,346 in 114 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,290 · 2025 $2,346
Food & beverage: $2,346
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $617 |
| ABBVIE INC. | 25 | $475 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $198 |
| Ipsen Biopharmaceuticals, Inc | 13 | $154 |
| Ardelyx, Inc. | 10 | $154 |
| GENZYME CORPORATION | 5 | $149 |
| PFIZER INC. | 5 | $93 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
Products named: TREMFYA, XIFAXAN, SKYRIZI, DUPIXENT, ENTYVIO, IQIRVO, IBSRELA, RINVOQ.
Industry payments across GA — which companies pay providers there.
